Formation Venture Engineering
Adam Hill is a seasoned professional in the life sciences sector with a robust background in technology and drug discovery. Currently involved with multiple organizations, Adam serves as a General Partner at Formation Venture Engineering and as Chief Technology Officer at Triple Sharp Venture Engineering. Previously, Adam held key leadership roles, including Senior Vice President at HotSpot Therapeutics, Inc. and Vice President at Plexium. Adam's career began at the Schering-Plough Research Institute and included significant positions at Millennium Pharmaceuticals and Novartis. Educational credentials include a D.Phil. in Chemistry and Pharmacology from the University of Oxford, along with postdoctoral studies at the University of Connecticut and Harvard University.
This person is not in the org chart
This person is not in any teams
Formation Venture Engineering
Venture engineering is a journey that begins with the end in sight. By recognizing the common pitfalls of building ventures and aligning stakeholders in a structure that pre-empts those pitfalls, it becomes positioned to deliver uncommonly reliable results. By investing in and building around game-changing technologies; humble truth-seeking to discover return potential; operational excellence; helping build teams from industry power brokers; and aligning with acquirers for the early exits with momentum toward rapid scale, this method aims to deliver uncommon value for both the entrepreneur, investor, and world at large.